Neuropathy

Neurology·MeSH: Neuropathy, Painful

Prevalence

3200.0 / 100K

Incidence

300.0 / 100K/yr

62 drugs in development·34 companies·3 clinical trials

Drug Pipeline by Phase

Approved(14)

Drug	Company
Amvuttra	Royalty Pharma plc (RPRX)
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
cutaquig	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
cuvitru	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
gammagard liquid	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
hizentra	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
hyqvia	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
Nucynta ER	COLLEGIUM PHARMACEUTICAL, INC (COLL)
Nucynta ER and Nucynta IR	COLLEGIUM PHARMACEUTICAL, INC (COLL)
ONPATTRO	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
tegsedi	AKCEA THERAPEUTICS, INC. (AKCA)
Tegsedi	PTC THERAPEUTICS, INC. (PTCT)
wainua	ASTRAZENECA PLC (AZN)
xembify	KORU Medical Systems Inc. Common Stock (DE) (KRMD)

Phase 3(27)

Drug	Company
at-007	Applied Therapeutics, Inc. (APLT)
AT-007 (govorestat)	Applied Therapeutics, Inc. (APLT)
Batoclimab	Immunovant, Inc. (IMVT)
claseprubart	Dianthus Therapeutics, Inc. /DE/ (DNTH)
Empasiprubart	ARGENX SE (ARGX)
Empasiprubart IV	ARGENX SE (ARGX)
eplontersen	IONIS PHARMACEUTICALS INC (IONS)
gamunex-c	Grifols S.A. (GRFS)
hyqvia	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
hyqvia	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
ivig	Sanofi (SNY)
IVIg	Sanofi (SNY)
IVIG	ARGENX SE (ARGX)
Nipocalimab	Crinetics Pharmaceuticals, Inc. (CRNX)
Nucresiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
riliprubart	Sanofi (SNY)
riliprubart	Sanofi (SNY)
riliprubart prefilled pen	Sanofi (SNY)
Riliprubart Prefilled Pen	Sanofi (SNY)
tak-411	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-411	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-771	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-771	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-881	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Vutrisiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
xembify	Grifols S.A. (GRFS)

Phase 2(8)

Drug	Company
amiket	IMMUNE PHARMACEUTICALS INC (IMNP)
argx-117	ARGENX SE (ARGX)
cenplacel-l	Celularity Inc. (CELU)
imeroprubart	Immunovant, Inc. (IMVT)
nyx-2925	Aptinyx Inc. (APTX)
sar445088	Sanofi (SNY)
son-080	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)
TAK-411	Merus N.V. (MRUS)

Phase 1(5)

Drug	Company
ART26.12	ARTELO BIOSCIENCES, INC. (ARTL)
cc8464	Pelthos Therapeutics Inc. (PTHS)
ketamir-2	MIRA PHARMACEUTICALS, INC. (MIRA)
NTLA-2001	Intellia Therapeutics, Inc. (NTLA)
VK0214	Viking Therapeutics, Inc. (VKTX)

Preclinical(4)

Drug	Company
ag10	Eidos Therapeutics, Inc. (EIDX)
prana bio nutrient medicinals	UNITED CANNABIS CORP (CNAB)
rpi-78m	NUTRA PHARMA CORP (NPHC)
sp16	Dogwood Therapeutics, Inc. (DWTX)

Unknown(1)

Drug	Company
nb-01	MetaVia Inc. (MTVA)

Phase 2/Phase 3(1)

Drug	Company
imvt-1402	Roivant Sciences Ltd. (ROIV)

Phase 4(2)

Drug	Company
Efgartigimod PH20 SC	ARGENX SE (ARGX)
Palmidrol	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 62 drugs in development for Neuropathy across 34 companies.

There are 3 clinical trials targeting Neuropathy tracked by BioSniper.

The estimated prevalence of Neuropathy is approximately 3200.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.